young or old, rich or poor, brain or heart, limbs or lungs
ISCHAEMIA is an unsolved problem.
We are on a mission to set up a world class Diagnostic, Treatment and Research Center in Calcutta for Ischaemic Diseases.
2. The Need
• Ischaemia1 has serious implications across a wide
range of medical2 conditions.
• While the current diagnostics approach for
ischaemic conditions is primitive and evaluative at
best, treatment in general have poor outcomes for
patients.
• Nature does not know how to repair. Neither do
we really know how to intervene.
O U R V I S I O N
To set up a world class Diagnostic, Treatment and Research
Center in Calcutta for Ischaemic Diseases
young or old, rich or poor, brain or heart, limbs or lungs
ISCHAEMIA is an unsolved problem
1 a restriction in blood supply to tissues, causing shortage of oxygen & glucose needed for cellular metabolism.
2 Coronary Artery Disease, Paralytic Stroke, Tissue Repair & Wound Management, Small-for-Date Live Births, Chemo- and
Radio- Therapy and Diabetic Nephropathy and Vasculopathy.
Michael Schumacher
3. The Opportunity
• Ischaemia is not only a real and present issue for the general
population, but is fast emerging as a critical area in the Lifestyle
healthcare segment.
• We want to focus on two underserved markets:
Wound Management and Cerebral & Neural Ischaemia
Our Business Proposition
01 A Diagnostics Center that uses a proprietary approach to assess and
predict ischaemic levels thereby helping doctors treat better
02 A Novel* Treatment Methodology and Product Line based on
Controlled Therapeutic Angiogenesis using Low Molecular Weight
Angiogenic Agents
T H E O P P O R T U N I T Y A N D O U R P L A N
We see serious opportunities in both Lifestyle and BoP market
segments. Our business plan has a potential global footprint.
* Please refer to the Technical Note or request us for one
debatosh@doctordatta.com
4. T H E T E A M
Experienced professional team with extensive research background
with IIT Bombay, UCLA Medical Center and Mayo Medical Center
Dr. Debatosh Datta
Founder and Chief Executive Officer
Former IIT Bombay Professor
Doctor and Scientist
Sanjukt K. Saha
Innovation Advisor
Indian Institute of Technology Alumnus
European School of Management & Technology MBA
Vijit Sunder
Innovation Advisor
MSc Global Health / McMaster & Maastricht University
BSc Science and Business / University of Waterloo
Dr. Anindita Banerjee
Co Founder and Chief Operating Officer
MD Biochemistry
Doctor and Scientist
Dr. VM Kurien
Technical Advisor
Madras Medical Mission
Cardiologist and Professor
5. Operational Readiness
• Tied up incubation support at the Science and Technology Park at IIT Kharagpur.
Advanced stage for receiving seed funding from the Department of Scientific and
Industrial Research [DSIR] – Government of India
• The business plan has been vetted and approved for an enterprise loan by the State
Bank of India. The core team is in place. Key positions are being actively scouted for. A
1500 square feet facility in Calcutta for the first diagnostics center has been identified.
Equipment and operational plan in place to start immediately.
• 150+ Clinician network is prepped and ready to start diagnostics engagement.
Product Pipeline
• The first product based on natural molecule is ready for launch. Research and
development for the entire product line is at an advanced stage.
• Technical and Clinical Collaborations with IIT Bombay, Madras Medical Mission and
Mayo Medical Center for research and development.
R E A D I N E S S T O E X E C U T E
Our business plan is revenue oriented with the Diagnostics
component and visionary with our Product Pipeline
We are looking for investors passionate about pioneering healthcare
Ask us for a detailed business plan